Economic outcomes associated with deep surgical site infection in patients with an open fracture of the lower limb by Parker, Benjamin A. et al.
  
 
 
 
warwick.ac.uk/lib-publications 
 
 
 
 
 
Manuscript version: Author’s Accepted Manuscript 
The version presented in WRAP is the author’s accepted manuscript and may differ from the 
published version or Version of Record. 
 
Persistent WRAP URL: 
http://wrap.warwick.ac.uk/106444                            
 
How to cite: 
Please refer to published version for the most recent bibliographic citation information.  
If a published version is known of, the repository item page linked to above, will contain 
details on accessing it. 
 
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work by researchers of the 
University of Warwick available open access under the following conditions.  
 
Copyright © and all moral rights to the version of the paper presented here belong to the 
individual author(s) and/or other copyright owners. To the extent reasonable and 
practicable the material made available in WRAP has been checked for eligibility before 
being made available. 
 
Copies of full items can be used for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge. Provided that the authors, title and full 
bibliographic details are credited, a hyperlink and/or URL is given for the original metadata 
page and the content is not changed in any way. 
 
Publisher’s statement: 
Please refer to the repository item page, publisher’s statement section, for further 
information. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk. 
 
1 
 
Economic outcomes associated with deep surgical site infection in patients with an open 
fracture of the lower limb 
Ben Parker1, Stavros Petrou1, James Masters3, Felix Achana1 Matthew L Costa123 
1Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Gibbet Hill Campus, 
Coventry, CV4 7AL, UK 
2University Hospitals Coventry and Warwickshire NHS Trust, Clifford Bridge Road, Coventry, CV2 
2DX, UK 
3Oxford Trauma, Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, 
University of Oxford, Oxford, OX3 9DU, UK 
 
Corresponding author: Professor Stavros Petrou S.Petrou@warwick.ac.uk 
Keywords: deep surgical site infection; open fracture; quality of life; healthcare costs; health 
economics 
 
 
 
 
 
 
 
 
2 
 
Abstract 
Aims: To estimate economic outcomes associated with deep surgical site infection (SSI) in patients 
with an open fracture of the lower limb. 
Patients: 460 UK patients recruited from twenty-four specialist trauma hospitals in the UK Major 
Trauma Network. 
Methods: Preference-based health-related quality of life outcomes, assessed using the EuroQol EQ-
5D-3L and the SF-6D, and economic costs (£, 2014-15 prices), were measured using participant-
completed questionnaires over the 12 months following injury. Descriptive statistics and 
multivariate regression analysis were used to explore the relationship between deep SSI and health 
utility scores, quality-adjusted life years (QALYs) and health and personal social service (PSS) costs. 
Results: Deep SSI was associated with lower EQ-5D-3L derived QALYs (adjusted mean difference -
0.102, 95% CI -0.202 to 0.001, p-value = 0.047) and increased health and social care costs (adjusted 
mean difference £1,950; 95%CI £1,383 to £5,285, p-value = 0.250) compared to patients without 
deep SSI over the 12 months following injury. 
Conclusion: Deep SSI may lead to significantly impaired health-related quality of life and increased 
economic costs. Our economic estimates can be used to inform clinical and budgetary service 
planning, and can act as data inputs into future economic evaluations of preventive or treatment 
interventions. 
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Introduction  
Fractures of the lower limb are significant injuries, which have long term consequences for patients. 
Of particular importance are open fractures. These injuries represent a major challenge to 
reconstructive trauma teams.  In the lower limb, the tibia is most often affected 1 . This reflects its 
paucity of soft tissue coverage. Treatment of the contamination and bone exposure is at the 
forefront of the orthoplastic paradigm 2. 
The growing expertise and centralisation of care pathways in major trauma networks has done much 
to improve care for these patients. Yet complications are a common occurrence in open lower limb 
fractures 3. Foremost among them is deep infection. The catastrophic consequences of deep 
infection in fractures are well characterised 4. Non-union, soft tissue coverage failure, systemic 
deterioration and diminished rehabilitation all add to the burden of misery for patients. Treatment 
for deep infection requires further surgery and extensive courses of antibiotics 5. Even with salvage 
procedures such as amputation there are no guarantees of success 6.  
The nature of the deep infection as both a complication and disease to be treated make it a resource 
intensive problem 7, 8. The burden is borne foremost by the patient. This may be psychological, 
financial, social and physical. The healthcare system in treating patients with deep infection is also 
burdened. Extensive inpatient stays, multiple procedures and outpatient visits may contribute 
significantly to the economic cost of caring for these patients.  
Attempts to understand the economic costs associated with deep infection after open fractures are 
limited 7, 8. We are not aware of any such analysis undertaken in the UK healthcare system. However, 
this is a critical area of study. Deep infection after any surgery is significant for the patient and 
treating centre. By quantifying the economic costs associated with this complication, efforts to 
reduce infection by devices, medical treatments and pathways can be justified and contextualised.  
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The Wound in Open Lower Limb Fracture (WOLLF) trial sought to assess the effectiveness of 
negative pressure wound therapy (NPWT) in patients with open lower limb fractures 9. Negative 
pressure wound therapy is a device used to manage the soft tissue defects associated with open 
fracture, among other indications.  A major part of the trial examined the cost-effectiveness as well 
as the clinical effectiveness of the device. This involved collecting detailed information around 
complications, on-going treatment and care needs. The trial-based health economic analysis 
collected data on economic costs to the health and social care systems and to patients, as well as 
data on preference-based health-related quality of life measures recommended for cost-
effectiveness purposes.  This study used these trial data to explore the health economic implications 
of deep infection after open fracture.  
 
 
Methods 
This study used data from the WOLLF study, a prospective randomised controlled trial that was 
embedded in the UK Major Trauma Network. The design and methods of WOLLF are described in 
detail elsewhere.10 Briefly, the trial recruited adult patients with open fractures of the lower limb 
graded as Gustilo-Anderson two or above, all of whom were treated in a Major UK Trauma Centre or 
Trauma Unit with joint orthopaedic and plastic surgical care.11 Patients were stratified by centre and 
Gustilo-Anderson grade. 
The data set used for this secondary analysis included all 460 participants in the WOLLF study, 
regardless of trial allocation. Two groups of patients were compared, those without and those with a 
diagnosis of deep SSI. Deep SSI was defined according to the Centres for Disease Control (CDC) 
definition.12 The CDC definition covers the first 30 days following surgery, unless an implant is in 
place in which case the follow up period is extended to 12 months. Deep SSI presenting within 12 
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months of the injury and any wound infection requiring continuing medical or surgical intervention 
after 30 days, including those leading to amputation, were also recorded as a deep SSI. In the WOLLF 
study, wounds were assessed and medical records reviewed at hospital discharge, or in the case of 
discharge before 30 days, at the first outpatient appointment (between 30 days and six weeks post-
injury as per standard UK clinical practice). Wounds were observed directly and research staff 
recorded the characteristics of any infection.  
Two sets of long-term economic consequences were measured within the WOLLF study: preference-
based health-related quality of life outcomes and economic costs. The WOLLF study collected data 
based on two preference-based health-related quality of life instruments, namely the EuroQol EQ-
5D-3L and the SF-6D, based on participant completion of the EQ-5D-3L and SF-12 measures at 
baseline and at 3, 6, 9 and 12 months post-randomisation.13, 14 Responses to the EQ-5D-3L 
descriptive system covering five dimensions (mobility, self-care, usual activities, pain and 
anxiety/depression) each with three severity levels (no problems, some or moderate problems, 
severe or extreme problems) were converted into health utility scores at each time point using the 
Dolan et al. UK algorithm, generating health utility scores ranging from -0.594 to 1.0.15 Responses to 
the SF-12 descriptive system covering eight health concepts (physical functioning, role limitations – 
physical, bodily pain, general health, vitality, social functioning, role limitations – emotional, mental 
health) were converted into SF-6D health utility scores at each time point using the Brazier et al. UK 
algorithm, generating health utility scores ranging from 0.345 to 1.0.16 Using each measure, quality-
adjusted life year (QALY) profiles were generated for each participant over the one year follow-up 
period, calculated as the area under the curve with linear interpolation. QALYs provide a “measure 
of the state of health of a person or group in which the benefits, in terms of length of life, are 
adjusted to reflect the quality of life. One QALY is equal to 1 year of life in perfect health”17. 
Economic costs were measured using participant-completed questionnaires at each time point, 
encompassing utilisation of hospital inpatient services, hospital outpatient services, community 
health and social care, medication use, and aids and adaptations. Resource inputs were valued using 
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primary and secondary cost sources. Costs were calculated for the initial period of hospitalisation, 
the period between hospital discharge and three months post-randomisation, and subsequently for 
each three month time period up to one year post-randomisation. Cumulative total costs were 
calculated from a UK National Health Service (NHS) and personal social services (PSS) perspective in 
accordance with national methodological guidance.18 Costs are reported in British pound sterling 
using 2015 prices. 
Differences at each time point in mean utility values and mean NHS and PSS costs, and differences in 
EQ-5D and SF-6D derived QALYs and cumulative NHS and PSS costs for the one year follow-up 
period, were estimated using Student’s t-tests. Linear regression models were estimated using 
ordinary least squares (OLS), with total NHS and PSS costs over each follow-up period regressed on 
age, gender, trial site, Gustilo-Anderson wound grade, diabetes diagnosis, height, weight and 
smoker. Whilst age and gender are standard controls, trial site was included to capture any 
differences in treatment between trial sites, wound grade to capture differences in the severity of 
the injury and the remaining covariates to capture potential differences in immune response which 
may regulate the impact of deep SSI. The same set of covariates was used with QALY estimates as 
the dependent variables, but with additional controls for baseline health utility values. The OLS 
estimator was selected in preference to a generalised linear model with alternative distributional 
families and link functions on the basis of Akaike information criterion statistics.19 The baseline 
analysis was completed using multiply imputed data, with a complete case analysis included as a 
sensitivity analysis. 
 
Results 
Table 1 summarises the demographic and clinical characteristics of the study population at baseline. 
The study population was comprised of 460 individuals, 35 of whom had deep SSI, 423 did not, with 
2 missing values. In the deep SSI group, the average age was 45 years, compared to 43 years in those 
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without deep SSI. Males comprised 74% of each group. The proportion of those with diabetes was 
slightly higher in those with deep SSI, at 11%, compared to 6% in those without. There was also a 
higher proportion of smokers in the deep SSI group, 46%, compared to 32% in those without. 
Table S1 of the accompanying supplementary information file summarises the mean EQ-5D utility 
scores and SF-6D utility scores for each group, at each timepoint, and reports tests of statistical 
significance for differences between mean utility scores in each group. Similarly, QALYs calculated 
over the one year follow-up period (using either EQ-5D or SF-6D utility scores) and NHS and PSS 
costs over each time period (initial hospitalisation and subsequent period to three months post-
randomisation, 3-6 months, 6-9 months, 9-12 months, 0-12 months) and for each cost category 
(hospital inpatient care, hospital outpatient care, community health and social care, medications, 
aids and adaptations) are reported together with tests of statistical significance for differences in 
values. 
Differences were found between EQ-5D-3L utility scores at 6 months (0.14 higher in those without 
deep SSI, p=0.038), 12 months (0.16 higher in those without deep SSI, p=0.023), as well as in EQ-5D-
3L QALYs calculated over the one year follow-up period (0.16 higher in those without deep SSI, 
p=0.01). However, these results were not replicated for the SF-6D.  
Regarding economic costs, hospital inpatient costs in the 3-6 month time period were higher in the 
deep SSI group (£2692 v £691, p=0.049). Total NHS and PSS costs were higher in the deep SSI group 
over the 0-6 month (£15598 v£12304, p=0.099) and 3-6 month (£3542 v £1597, p=0.095) time 
periods. However, total NHS and PSS costs were higher in the group without deep SSI in the 6-9 
month time period (£1091 v £623, p=0.068). 
Table 2 details the results of the multivariate analyses based on multiple imputation of missing data, 
considering the effects of deep SSI on total NHS and PSS costs over each follow-up period, as well as 
on QALYs calculated using either EQ-5D-3L or SF-6D utility scores over the one year follow-up period. 
Using multiply imputed data, there was a statistically significant difference in QALYs calculated using 
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EQ-5D-3L utility scores at the 5% significance level (p=0.047). Results based on analysis of complete 
cases are presented in Table S2 of the supplementary file for completeness.  Considering the 
complete case analysis, deep SSI was not a statistically significant predictor of a difference in QALYs 
calculated using the EQ-5D-3L at the 5% significance level (p=0.079). For both the multiple 
imputation and complete case analyses, deep SSI was not found to have a statistically significant 
association with total NHS and PSS costs over any of the time periods considered or with SF-6D 
generated QALYs calculated over the one year follow-up period.  
 
 
 
 
Discussion 
This study is the first, to our knowledge, to assess the economic outcomes associated with deep 
surgical site infection in patients with an open fracture of the lower limb. The use of high quality 
prospectively collected data is a major strength of this study. This is very relevant to open fracture 
populations who typically have very poor long-term follow up rates. Another major strength is the 
multicentre source of patients. This is critical as it improves the generalisability of the findings across 
heath care settings, particularly within the UK NHS.  
The total number of patients with deep infection (n=35) is relatively small. This means that the 
summative analyses here can be influenced by a few clinical events or treatments. Furthermore 
follow up is limited to 12 months. Other studies have shown that the consequences of complications 
after open fracture persist well after this window 20, and therefore our estimates can be viewed as 
conservative assessments of the long-term economic implications of deep surgical site infection in 
patients with an open fracture of the lower limb. 
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Other studies have considered complications following lower limb injury. Chung and colleagues 
studied over 500 major lower limb injuries and assessed the cost implications as part of the Lower 
Extremity Assessment Project (LEAP) 7. The LEAP patient cohort was similar to the WOLLF cohort, but 
was not limited to open fractures. However, the LEAP analysis was undertaken from a healthcare 
provider perspective only 21. In turn, the healthcare context for the LEAP analysis is highly different 
to the UK NHS and no specific economic analysis was undertaken of the infected cases. The LEAP  
findings have been replicated in other studies of severe lower limb injury 22. 
In our study, there was a statistically significant difference in EQ-5D-3L QALYs generated over the 
one year follow-up period. Whilst this finding was not replicated for the SF-6D, the overall difference 
in SF-6D utility score at 12 months exceeds the 0.03 minimally important clinical difference (12). As 
is intuitive, economic costs were higher in the deep SSI group at 12 months. These costs were borne 
both by the NHS and social care systems and by patients and their carers.  The difference in total 
NHS and PSS costs over the 12 month follow-up period was estimated at £1242. This figure may be 
of benefit to clinical and budgetary service planning. More generally, the economic estimates 
generated by this analysis can act as data inputs into future economic evaluations of preventive or 
treatment interventions. 
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In conclusion, the entirely expected finding of higher economic costs within the deep infection 
cohort should empower the clinician to be aggressive with identifying infection expeditiously and 
being as rigorous as possible in reducing infection.  When viewed in conjunction with our findings on 
preference-based health-related quality of life outcomes, our estimates are important too for the 
patient who can now be informed that deep surgical site infection in open fractures of the lower 
limb will have considerable long term consequences through which they will need significant 
support.  
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